PetCaseFinder

Peer-reviewed veterinary case report

New blood test using parasite particles to detect visceral

By Allecineia Bispo da Cruz et al.·Published in Journal of Parasitology Research·2025·Parasitology and Mycology Center, GB·View original on DOAJ

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Performance of Extracellular Vesicles From Leishmania (Leishmania) infantum for Serological Diagnosis of Human and Canine Visceral Leishmaniasis

Species:
dog

Plain-English summary

A study found that a new test using tiny particles from the Leishmania parasite could help diagnose visceral leishmaniasis (VL) in both dogs and humans. In dogs with VL, the test identified 60 out of 63 cases, showing a high accuracy rate of 95%. The test was also effective in humans, detecting VL in 73 out of 74 cases with an impressive 98.64% accuracy. This new method could improve how veterinarians and doctors diagnose this serious disease in pets and people, helping to ensure timely treatment.

People also search for: dog leishmaniasis symptoms · canine visceral leishmaniasis diagnosis · how to test for leishmaniasis in dogs

Abstract

Visceral leishmaniasis (VL) is a zoonotic disease in which dogs are the main reservoirs. Until now, the serological tests do not present satisfactory sensitivity for diagnosis of these hosts. One of the functions of extracellular vesicles (EVs) is related to immunological host response. Here, we evaluated the ability of EVs released by Leishmania (Leishmania) infantum promastigotes (Leish-EVs) to be source of antigens for use in serological diagnosis for human visceral leishmaniasis (HumVL) and canine visceral leishmaniasis (CanVL). A total of 300 sera were tested. The 155 human sera were divided into 4 groups and 145 canine sera into 3 groups. In human sera, Leish-EVs were reactive in 73/74 sera from patients with VL (Hum-VL) with 98.64% sensitivity. The 26 sera from healthy individuals (NH) and 27 from individuals with asymptomatic toxoplasmosis (ATx) were nonreagent (100% specificity). Leish-EVs-ELISA had cross-reactivity or inconclusive results in 13.5% of sera from Chagas disease patients (CD). In canine sera, Leish-EVs were reactive in 60/63 sera from dogs with CanVL (Can-VL) with 95.24% sensitivity. Leish-EVs were nonreactive in sera from 57 dogs without Can-VL (NC) and 25 with other infections (OIs) with 100% specificity. Hum-VL produced more IgG1 against Leish-EVs than IgG2, IgG3, and IgG4. Can-VL produced more IgG2 against Leish-EVs than IgG1. In conclusion, this study provides evidence that Leish-EVs released by L. (L.) infantum when used as antigen in ELISA identified the host antibodies. The methodology was effective for serological diagnosis of VL, since results exhibited good sensitivity and specificity for human and canine sera.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on DOAJ: https://doi.org/10.1155/japr/8355886